Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

VectivBio Holding AG (VECT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.62+0.07 (+1.26%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close5.55
Open5.87
Bid2.25 x 800
Ask7.50 x 3000
Day's Range5.62 - 5.88
52 Week Range2.74 - 12.55
Volume6,887
Avg. Volume26,003
Market Cap251.446M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-3.23
Earnings DateApr 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est20.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for VECT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • VectivBio Holding AG
    Daily – Vickers Top Buyers & Sellers for 01/19/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    5 months agoArgus Research
View more
  • GlobeNewswire

    VectivBio Announces Pricing of $30 Million Public Offering of Ordinary Shares

    Combined Gross Proceeds from Public Offering and Private Sale Total $50 MillionBASEL, Switzerland, June 14, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the pricing of a follow-on public offering of 5,715,000 ordinary shares at a public offering price of $5.25 per share for aggregate gross proceeds of approximately $30 million, before

  • GlobeNewswire

    VectivBio Announces Launch of Public Offering of Ordinary Shares

    BASEL, Switzerland, June 14, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the launch of a follow-on public offering of its ordinary shares. In addition, VectivBio expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the ordinary shares to be sold in the offering on the same terms and conditions. The

  • Simply Wall St.

    What Percentage Of VectivBio Holding AG (NASDAQ:VECT) Shares Do Insiders Own?

    A look at the shareholders of VectivBio Holding AG ( NASDAQ:VECT ) can tell us which group is most powerful. Insiders...

Advertisement
Advertisement